Trial Profile
A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 649868 (Primary) ; Atorvastatin; Simvastatin
- Indications Cardiovascular disorders; Hypercholesterolaemia; Sleep disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors GSK
- 25 Feb 2011 New trial record